Literature DB >> 33669363

Thyroid Carcinoma: Phenotypic Features, Underlying Biology and Potential Relevance for Targeting Therapy.

Jinwei Hu1, Isabella J Yuan1, Saied Mirshahidi2, Alfred Simental1, Steve C Lee1, Xiangpeng Yuan1.   

Abstract

Thyroid carcinoma consists a group of phenotypically heterogeneous cancers. Recent advances in biological technologies have been advancing the delineation of genetic, epigenetic, and non-genetic factors that contribute to the heterogeneities of these cancers. In this review article, we discuss new findings that are greatly improving the understanding of thyroid cancer biology and facilitating the identification of novel targets for therapeutic intervention. We review the phenotypic features of different subtypes of thyroid cancers and their underlying biology. We discuss recent discoveries in thyroid cancer heterogeneities and the critical mechanisms contributing to the heterogeneity with emphases on genetic and epigenetic factors, cancer stemness traits, and tumor microenvironments. We also discuss the potential relevance of the intratumor heterogeneity in understanding therapeutic resistance and how new findings in tumor biology can facilitate designing novel targeting therapies for thyroid cancer.

Entities:  

Keywords:  cancer stem cells; epigenetics; genetics; heterogeneity; targeting therapy; thyroid carcinoma; tumor microenvironments

Mesh:

Year:  2021        PMID: 33669363      PMCID: PMC7920269          DOI: 10.3390/ijms22041950

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  216 in total

1.  The role of microRNA genes in papillary thyroid carcinoma.

Authors:  Huiling He; Krystian Jazdzewski; Wei Li; Sandya Liyanarachchi; Rebecca Nagy; Stefano Volinia; George A Calin; Chang-Gong Liu; Kaarle Franssila; Saul Suster; Richard T Kloos; Carlo M Croce; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

Review 2.  Anaplastic thyroid carcinoma: a therapeutic challenge.

Authors:  K B Ain
Journal:  Semin Surg Oncol       Date:  1999 Jan-Feb

Review 3.  A New View of Pathway-Driven Drug Resistance in Tumor Proliferation.

Authors:  Ruth Nussinov; Chung-Jung Tsai; Hyunbum Jang
Journal:  Trends Pharmacol Sci       Date:  2017-02-27       Impact factor: 14.819

4.  Activation of mTOR signaling in medullary and aggressive papillary thyroid carcinomas.

Authors:  Maria A Kouvaraki; Chrysoula Liakou; Adriani Paraschi; Konstantinos Dimas; Efstratios Patsouris; Sofia Tseleni-Balafouta; George Z Rassidakis; Dimitrios Moraitis
Journal:  Surgery       Date:  2011-12       Impact factor: 3.982

5.  Integrated genomic characterization of papillary thyroid carcinoma.

Authors: 
Journal:  Cell       Date:  2014-10-23       Impact factor: 41.582

6.  Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis.

Authors:  Patrick W B Derksen; Xiaoling Liu; Francis Saridin; Hanneke van der Gulden; John Zevenhoven; Bastiaan Evers; Judy R van Beijnum; Arjan W Griffioen; Jacqueline Vink; Paul Krimpenfort; Johannes L Peterse; Robert D Cardiff; Anton Berns; Jos Jonkers
Journal:  Cancer Cell       Date:  2006-11       Impact factor: 31.743

7.  Forskolin, 8-Br-3',5'-cyclic adenosine 5'-monophosphate, and catalytic protein kinase A expression in the nucleus increase radioiodide uptake and sodium/iodide symporter protein levels in RET/PTC1-expressing cells.

Authors:  Anjli Venkateswaran; Derek K Marsee; Steven H Green; Sissy M Jhiang
Journal:  J Clin Endocrinol Metab       Date:  2004-12       Impact factor: 5.958

8.  Hedgehog signaling regulates brain tumor-initiating cell proliferation and portends shorter survival for patients with PTEN-coexpressing glioblastomas.

Authors:  Qijin Xu; Xiangpeng Yuan; Gentao Liu; Keith L Black; John S Yu
Journal:  Stem Cells       Date:  2008-09-11       Impact factor: 6.277

9.  Highly recurrent TERT promoter mutations in human melanoma.

Authors:  Franklin W Huang; Eran Hodis; Mary Jue Xu; Gregory V Kryukov; Lynda Chin; Levi A Garraway
Journal:  Science       Date:  2013-01-24       Impact factor: 47.728

View more
  8 in total

1.  Prophylactic central lymph node dissection performed selectively with cN0 papillary thyroid carcinoma according to a risk-scoring model.

Authors:  Xiang Zhong; Yunpeng Lu; Xu Yin; Quhui Wang; Feiran Wang; Zhixian He
Journal:  Gland Surg       Date:  2022-02

2.  CircNRIP1 Exerts Oncogenic Functions in Papillary Thyroid Carcinoma by Sponging miR-653-5p and Regulating PBX3 Expression.

Authors:  Lijun Fu; Jia Huo; Habibullah Fitrat; Yujing Kong; Lingyu Zhang; Chaoyang Shang; Guoquan Li; Feihong Ji; Xinghao Fu; Xinguang Qiu
Journal:  J Oncol       Date:  2022-05-19       Impact factor: 4.501

Review 3.  Intratumoral Heterogeneity in Differentiated Thyroid Tumors: An Intriguing Reappraisal in the Era of Personalized Medicine.

Authors:  Antonio Ieni; Roberto Vita; Cristina Pizzimenti; Salvatore Benvenga; Giovanni Tuccari
Journal:  J Pers Med       Date:  2021-04-23

4.  Potential Novel Modules and Hub Genes as Prognostic Candidates of Thyroid Cancer by Weighted Gene Co-Expression Network Analysis.

Authors:  Zhiqiang Shi; Xinghui Li; Long Zhang; Yilang Luo; Bikal Shrestha; Xuegang Hu
Journal:  Int J Gen Med       Date:  2021-12-07

Review 5.  Can We Predict Differentiated Thyroid Cancer Behavior? Role of Genetic and Molecular Markers.

Authors:  Rita Niciporuka; Jurijs Nazarovs; Arturs Ozolins; Zenons Narbuts; Edvins Miklasevics; Janis Gardovskis
Journal:  Medicina (Kaunas)       Date:  2021-10-19       Impact factor: 2.948

6.  ZHX2 inhibits thyroid cancer metastasis through transcriptional inhibition of S100A14.

Authors:  Yankun Zhang; Min Sun; Lifen Gao; Xiaohong Liang; Chunhong Ma; Jinghui Lu; Xuetian Yue
Journal:  Cancer Cell Int       Date:  2022-02-12       Impact factor: 5.722

7.  Clinical Efficacy of Levothyroxine Sodium plus I 131 in the Treatment of Patients with Thyroidectomy and Its Effect on the Levels of Thyroglobulin and Thyrotropin.

Authors:  Ya-Ling Pang; Yan-Ping Wang; Kun Cheng
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-02       Impact factor: 2.650

8.  Research on the Expression Level of Matrin-Type Zinc Finger Protein 4 Gene in T Cells of Thyroid Carcinoma Tissue.

Authors:  Qian Zhang; Yingchun Song; Shengguang Chen; Zhongwei Lv
Journal:  Contrast Media Mol Imaging       Date:  2022-08-18       Impact factor: 3.009

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.